These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 19302020)

  • 41. [Infection with hepatitis C virus. Introduction].
    Degos F
    Rev Prat; 2000 May; 50(10):1058-9. PubMed ID: 10960306
    [No Abstract]   [Full Text] [Related]  

  • 42. Hepatitis C: staying the course.
    Garber K
    Nat Biotechnol; 2007 Dec; 25(12):1379-81. PubMed ID: 18066031
    [No Abstract]   [Full Text] [Related]  

  • 43. Australia commits funds to curb hepatitis C epidemic.
    McCall C
    Lancet; 2016 Jan; 387(10017):419. PubMed ID: 26869556
    [No Abstract]   [Full Text] [Related]  

  • 44. Doing better at doing good.
    Nat Biotechnol; 2008 Apr; 26(4):357. PubMed ID: 18391995
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Epidemiological characteristics of hepatitis C in China, 1997-2011].
    Qin QQ; Guo W; Wang LY; Yan RX; Ge L; Wang L; Cui Y
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 Jun; 34(6):548-51. PubMed ID: 24125600
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection.
    ; McCaughan GW; Omata M; Amarapurkar D; Bowden S; Chow WC; Chutaputti A; Dore G; Gane E; Guan R; Hamid SS; Hardikar W; Hui CK; Jafri W; Jia JD; Lai MY; Wei L; Leung N; Piratvisuth T; Sarin S; Sollano J; Tateishi R
    J Gastroenterol Hepatol; 2007 May; 22(5):615-33. PubMed ID: 17444847
    [No Abstract]   [Full Text] [Related]  

  • 47. Hepatitis B and C virus--prevalence and prevention in health care workers.
    Duseja A; Arora L; Masih B; Singh H; Gupta A; Behera D; Chawla YK; Dhiman RK
    Trop Gastroenterol; 2002; 23(3):125-6. PubMed ID: 12693154
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmaceutical company-sponsored disease management programs.
    Jedrey CM; Chaurette KA; Winn LB
    Manag Care Q; 2002; 10(1):56-60. PubMed ID: 15988959
    [No Abstract]   [Full Text] [Related]  

  • 49. World Gastroenterology Organisation global guidelines: diagnosis, management and prevention of hepatitis C April 2013.
    Umar M; Khan AG; Abbas Z; Arora S; Asifabbas N; Elewaut A; Esmat G; Foster G; Fried M; Goh KL; Hamama TB; Imawari M; Isakov V; Krabshuis J; LaBrecque D; Lemair A; Malfertheiner P; Ryder S; Schiedermaier P; Stimac D; Tandon R; Villamil F; Zapata R; Ferenci P;
    J Clin Gastroenterol; 2014 Mar; 48(3):204-17. PubMed ID: 24504078
    [No Abstract]   [Full Text] [Related]  

  • 50. The clinical importance of hepatitis C genotyping in the United States.
    O'Brien S
    MLO Med Lab Obs; 2013 Nov; 45(11):16-7. PubMed ID: 24313119
    [No Abstract]   [Full Text] [Related]  

  • 51. The new hepatitis C paradigm: a synergy of diagnostics and drug therapy.
    Cloherty G
    MLO Med Lab Obs; 2014 Sep; 46(9):34-5. PubMed ID: 25252400
    [No Abstract]   [Full Text] [Related]  

  • 52. Low accuracy of the national reporting system of acute hepatitis C infection in Taiwan, 1995-2004.
    Kee KM; Hung CM; Wang JH; Hung CH; Chen PF; Lin KS; Lu SN
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1289-94. PubMed ID: 20594258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hepatitis C: Part I. Routine serologic testing and diagnosis.
    Moyer LA; Mast EE; Alter MJ
    Am Fam Physician; 1999 Jan; 59(1):79-88, 91-2. PubMed ID: 9917576
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hepatitis C virus prevention, care, and treatment: from policy to practice.
    Ward JW; Valdiserri RO; Koh HK
    Clin Infect Dis; 2012 Jul; 55 Suppl 1():S58-63. PubMed ID: 22715216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The evolution of non-A, non-B hepatitis: hepatitis C and hepatitis E].
    Melino C; Cristiani F; Cadelano A
    Clin Ter; 1992 Jan; 140(1):59-69. PubMed ID: 1326424
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Frequencies of hepatitis B and C infections among haemodialysis and peritoneal dialysis patients in Asia-Pacific countries: analysis of registry data.
    Johnson DW; Dent H; Yao Q; Tranaeus A; Huang CC; Han DS; Jha V; Wang T; Kawaguchi Y; Qian J
    Nephrol Dial Transplant; 2009 May; 24(5):1598-603. PubMed ID: 19096083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Health care: Make pharma justify the price of drugs.
    Bertele' V; Garattini S
    Nature; 2015 Jul; 523(7560):290. PubMed ID: 26178957
    [No Abstract]   [Full Text] [Related]  

  • 58. HCV positivity rate in the seronegative blood donors in China.
    Yang Z; Han YX; Jiang JD; Yang Z; Yu YX; Qiu Y
    Biomed Pharmacother; 2009 May; 63(4):319-20. PubMed ID: 19246175
    [No Abstract]   [Full Text] [Related]  

  • 59. CDC issues new recommendations for the prevention and control of hepatitis C virus infection.
    Rose VL
    Am Fam Physician; 1999 Mar; 59(5):1321-3. PubMed ID: 10088882
    [No Abstract]   [Full Text] [Related]  

  • 60. When to screen for hepatitis C virus. Applying the principles of evidence-based medicine.
    Hummel J
    JAAPA; 2000 Sep; 13(9):77-82. PubMed ID: 11521625
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.